GPR119
GPR119 is G-protein-coupled receptor for lipid amides OEA (oleoylethanolamide) and LPC (lysophosphatidylcholine). It may function in glucose homeostasis and insulin secretion. Act as a potential therapeutic target for type 2 diabetes.
Products for GPR119
- Cat.No. Product Name Information
-
GC40406
2-Oleoyl Glycerol
2-Monoolein, 2-OG
2-Oleoyl glycerol (2-OG) is a natural monoacylglycerol with an 18:1 oleoyl group at the sn-2 position of glycerol.
-
GC19033
APD597
JNJ-38431055
APD597 is a GPR119 agonist intended for the treatment of type 2 diabetes, with EC50 of 46 nM for hGPR119. -
GC12738
APD668
JNJ-28630368
Potent GPR119 agonist -
GC14944
AR 231453
GPR119 agonist,potent and selective
-
GC12018
AS 1269574
GPR119 receptor agonist
-
GC31508
Firuglipel
DS-8500a
Firuglipel (DS-8500a) is an orally available, potent and selective GPR119 agonist. -
GC11434
GSK1292263
Novel GPR119 agonist
-
GC12514
MBX-2982
An agonist of GPR119
-
GC13294
PSN 375963 hydrochloride
PSN 375963 hydrochloride is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively.
-
GC10365
PSN632408
Human and mouse GPR119 agonist